Literature DB >> 28639326

Bone marrow hematons: An access point to the human hematopoietic niche.

Alexandre Janel1,2, Juliette Berger1,2,3, Céline Bourgne1,2, Richard Lemal2,4, Nathalie Boiret-Dupré1, Frédérique Dubois-Galopin5, Pierre Déchelotte6, Charlotte Bothorel6, Eric Hermet4, Sara Chabi7, Jacques-Olivier Bay2,4, Céline Lambert8, Bruno Pereira8, Françoise Pflumio6, Rima Haddad6, Marc G Berger1,2,3,4.   

Abstract

To understand the complex interactions between hematopoietic stem cells and the bone marrow niche, a human experimental model is needed. Our hypothesis is that hematons are an appropriate ex vivo model of human bone marrow. We analyzed the hierarchical hematopoietic cell content and the tissue organization of single hematons from healthy donors. Most (>90%) hematons contained precursors of all cell lineages, myeloid progenitors, and LTC-ICs without preferential commitment. Approximately, half of the hematons could generate significant levels of lympho-myeloid hematopoiesis after transplantation in an NSG mouse model, despite the low absolute numbers of transplanted CD34+ cells. Mesenchymal STRO-1+ and/or CD271+ cells formed a critical network that preserved hematon cohesion, and STRO-1+ cells colocalized with most hematopoietic CD34+ cells (68%). We observed an influence of age and gender. These structures represent a particularly attractive model for studying the homeostasis of the bone marrow niche and pathological changes that occur during diseases.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 28639326     DOI: 10.1002/ajh.24830

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  1 in total

1.  Effective Label-Free Sorting of Multipotent Mesenchymal Stem Cells from Clinical Bone Marrow Samples.

Authors:  Silvia Zia; Carola Cavallo; Ilaria Vigliotta; Valentina Parisi; Brunella Grigolo; Roberto Buda; Pasquale Marrazzo; Francesco Alviano; Laura Bonsi; Andrea Zattoni; Pierluigi Reschiglian; Barbara Roda
Journal:  Bioengineering (Basel)       Date:  2022-01-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.